James Rolke
Vermögen: 89 275 $ am 31.05.2026
Vermögen: 89 275 $ am 31.05.2026
James M.
Rolke is Chief Executive Officer & Director at Revelation Biosciences Sub, Inc. since 2020.
Mr. Rolke is Chairman & Chief Executive Officer at Revelation Biosciences, Inc. starting in 2025.
Mr. Rolke is Director at Revelation Therapeutics LLC.
Former positions include Associate Director-Pharmaceutical Development at Mersana Therapeutics, Inc. from 2006 to 2007, Operations Director at Prospect Therapeutics, Inc. from 2006 to 2009, Associate Scientist at Alpha-Beta Technology, Inc., Chief Scientific Officer at La Jolla Pharmaceutical Co. from 2017 to 2020, Manager-Process Development at Glycogenesys, Inc. from 2003 to 2006, Chief Technology Officer at Pluromed, Inc. from 2009 to 2012, Principal Scientist at Surgical Sealants, Inc., and Scientist at Geltex, Inc. Education includes undergraduate studies at Keene State College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2026 | 81 530 ( 2,09 % ) | 89 275 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Vorstandsvorsitzender | 01.05.2020 |
Revelation Therapeutics LLC
Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Direktor/Vorstandsmitglied | - |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Vorstandsvorsitzender | 01.05.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 31.05.2020 |
Pluromed, Inc.
Pluromed, Inc. Medical SpecialtiesHealth Technology Manufactures and markets disposable medical devices | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Corporate Officer/Principal | 01.05.2009 |
| MERSANA THERAPEUTICS | Corporate Officer/Principal | 01.01.2007 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Corporate Officer/Principal | 01.01.2006 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Alpha-Beta Technology, Inc.
Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products | Electronic Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Commercial Services |
Pluromed, Inc.
Pluromed, Inc. Medical SpecialtiesHealth Technology Manufactures and markets disposable medical devices | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Keene State College
Keene State College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Health Technology |
Surgical Sealants, Inc. | |
Revelation Therapeutics LLC
Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Revelation Biosciences, Inc.
Revelation Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics and diagnostics for viral infections | Health Technology |
Geltex, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen